A derivative of staurosporine (CGP 41 : 251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumoractivity. (vol 43, pg 851, 1989)
T. Meyer et al., A derivative of staurosporine (CGP 41 : 251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumoractivity. (vol 43, pg 851, 1989), INT J CANC, 81(4), 1999, pp. 669-669